Michael L Kranda - Net Worth and Insider Trading
Michael L Kranda Net Worth
The estimated net worth of Michael L Kranda is at least $82,158 dollars as of 2024-09-20. Michael L Kranda is the Director of PTC Therapeutics Inc and owns about 2,242 shares of PTC Therapeutics Inc (PTCT) stock worth over $82,158. Details can be seen in Michael L Kranda's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael L Kranda has not made any transactions after 2015-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael L Kranda
Michael L Kranda Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael L Kranda owns 1 companies in total, including PTC Therapeutics Inc (PTCT) .
Click here to see the complete history of Michael L Kranda’s form 4 insider trades.
Insider Ownership Summary of Michael L Kranda
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2015-03-16 | director |
Michael L Kranda Latest Holdings Summary
Michael L Kranda currently owns a total of 1 stock. Michael L Kranda owns 2,242 shares of PTC Therapeutics Inc (PTCT) as of March 16, 2015, with a value of $82,158.
Latest Holdings of Michael L Kranda
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2015-03-16 | 2,242 | 36.65 | 82,158 |
Holding Weightings of Michael L Kranda
Michael L Kranda Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael L Kranda has made a total of 0 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years. The most-recent trade in PTC Therapeutics Inc is the sale of 2,500 shares on March 16, 2015, which brought Michael L Kranda around $182,025.
Insider Trading History of Michael L Kranda
- 1
Michael L Kranda Trading Performance
Michael L Kranda Ownership Network
Michael L Kranda Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
Michael L Kranda is the director of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Development Officer Matthew B. Klein .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, Michael L Kranda made no insider transaction in PTC Therapeutics Inc (PTCT). Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,771 shares made by Eric Pauwels , a net sale of 39,197 shares made by Christine Marie Utter , and a net sale of 23,666 shares made by Matthew B. Klein .
In summary, during the past 3 months, insiders sold 2,269 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 2,269 shares. During the past 18 months, 270,326 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 262,626 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
Michael L Kranda Mailing Address
Above is the net worth, insider trading, and ownership report for Michael L Kranda. You might contact Michael L Kranda via mailing address: C/o Vulcan Ventures Incorporated, 505 Fifth Avenue, Suite 900, Seattle Wa 98104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
